Information:
Error:
ID
12292
Description
An open-label, multicenter, randomized, comparative, phase III study to evaluate the efficacy and safety of rituximab plus fludarabine and cyclophosphamide (FCR) versus fludarabine and cyclophosphamide alone (FC) in previously treated patients with CD20 positive B-cell chronic lymphocytic leukemia (CLL). FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients NCT00090051 Roche BO17072
Keywords
Versions (3)
- 9/30/15 9/30/15 -
- 10/27/15 10/27/15 -
- 11/3/15 11/3/15 - Julian Varghese
Uploaded on
November 3, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
CLL History BO17072 NCT00090051
History of Chronic lymphocytic leukemia NCT0090051
- StudyEvent: ODM
Similar models
History of Chronic lymphocytic leukemia NCT0090051
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Date
Item
Date of first diagnosis
date
C2316983 (UMLS CUI [1])
CL Item
yes (-> specify below) (1)
C1705108 (UMLS CUI-1)
CL Item
no (2)
C1298908 (UMLS CUI-1)
CL Item
A (1)
C2698392 (UMLS CUI-1)
CL Item
B (2)
C2698393 (UMLS CUI-1)
CL Item
C (3)
C2698394 (UMLS CUI-1)
Date of last progression
Item
Date of last progression
date
C0011008 (UMLS CUI [1])
CL Item
peripheral blood (1)
C0229664 (UMLS CUI-1)
CL Item
lymph nodes (2)
C0024204 (UMLS CUI-1)
CL Item
bone marrow (3)
C0005953 (UMLS CUI-1)
CL Item
other (-> specify below) (4)
C0205394 (UMLS CUI-1)
Other progression
Item
Other progression
text
C0178874 (UMLS CUI [1])
CL Item
A (1)
C2698392 (UMLS CUI-1)
CL Item
B (2)
C2698393 (UMLS CUI-1)
CL Item
C (3)
C2698394 (UMLS CUI-1)
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
Item
Amendment C onwards
integer
C1704632 (UMLS CUI [1])
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)